Response to letter by Golestanieraghi regarding article, “Association between vasopressin administration and mortality in patients with cardiogenic shock”

IF 3.4 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

American heart journal Pub Date : 2026-02-01 Epub Date: 2025-12-03 DOI:10.1016/j.ahj.2025.09.002

Dhruv Sarma BMBCh , Aniket S Rali MD , Jacob C Jentzer MD

引用次数: 0

查看原文本刊更多论文

对Golestanieraghi关于《心源性休克患者抗利尿激素使用与死亡率的关系》一文的回复

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American heart journal 医学-心血管系统

CiteScore

8.20

自引率

2.10%

发文量

214

审稿时长

38 days

期刊介绍： The American Heart Journal will consider for publication suitable articles on topics pertaining to the broad discipline of cardiovascular disease. Our goal is to provide the reader primary investigation, scholarly review, and opinion concerning the practice of cardiovascular medicine. We especially encourage submission of 3 types of reports that are not frequently seen in cardiovascular journals: negative clinical studies, reports on study designs, and studies involving the organization of medical care. The Journal does not accept individual case reports or original articles involving bench laboratory or animal research.